The drug spurred about 10% weight loss over 10 months, though that finding came alongside high rates of gastrointestinal side effects that “alarmed” one analyst.
An article from
Dive Brief
//
Obesity drugs
The drug spurred about 10% weight loss over 10 months, though that finding came alongside high rates of gastrointestinal side effects that “alarmed” one analyst.
An experimental GLP-1 pill helped people with obesity or overweight lose as much as 12.1% of their body weight in just 36 weeks.…
Hengrui/Kailera's GLP-1 pill HRS-7535 met obesity & diabetes China trial endpoints but showed high nausea & vomiting, raising…
AstraZeneca’s GLP-1 pill showed promise in mid-stage obesity and diabetes studies, but it may still be too early to determine how…
A next-gen Eli Lilly obesity drug led to bariatric-surgery levels of weight loss in a study, but also saw patients dropping out…
Eli Lilly's pill, orforglipron, is one step closer to becoming the first new, needle-free alternative in the booming market for…
An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could…
